Another study found that PDAC tumor cells releasing IL-33 depended on the intratumoral fungal mycobiome, and genetic deletion of IL-33 or anti-fungal treatment in murine PDAC could reduce Th2 and ILC2 recruitment and improve survival (80). Here, IL33 is linked to neoplasm.